Clinical Trials

Phase 2 Not yet recruiting

Nasopharyngeal Carcinoma

NCT07331428 2026-01-09

MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC

25 enrolled

Phase 2 Not yet recruiting

Nasopharyngeal Carcinoma

NCT07252375 2025-11-26

A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma

35 enrolled

Nasopharyngeal Carcinoma

NCT07088484 2025-07-28

Watch-and-Wait After Immunochemotherapy in Locally Recurrent Nasopharyngeal Carcinoma

Not yet recruiting

50 enrolled

Phase 3 Not yet recruiting

Nasopharyngeal Carcinoma

NCT06775756 2025-01-15

Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal Cancer

474 enrolled

Phase NA Not yet recruiting

Nasopharyngeal Carcinoma

NCT06572293 2024-10-16

Effect of Nurse-Led Individualized Follow-Up Intervention on Patients With Nasopharyngeal Carcinoma

250 enrolled

Nasopharyngeal Carcinoma

NCT05099978 2024-09-04

A-TRAIN

BreastGynecologicHead & Neck

506 enrolled

Nasopharyngeal Carcinoma, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06331845 2024-03-26

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

Phase 2 Not yet recruiting

39 enrolled

Nasopharyngeal Carcinoma

NCT06136962 2023-11-18

Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life

500 enrolled

Phase 3 Not yet recruiting

Nasopharyngeal Carcinoma

NCT06095167 2023-10-23

Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC

476 enrolled

Nasopharyngeal Carcinoma

NCT05202626 2023-10-17

Detection and Biopsy Guidance of Nasopharyngeal Carcinoma Based on Artificial Intelligence and Endoscopic Images

100 enrolled

Nasopharyngeal Carcinoma

NCT05519956 2022-09-19

Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines

Phase 3 Unknown

398 enrolled

Nasopharyngeal Carcinoma

NCT04955886 2021-07-09

Surufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma

14 enrolled

Nasopharyngeal Carcinoma

NCT04745741 2021-04-29

Evaluating the Rationality of the International Guideline About Selective Coverage of Level Ib in CTV With NPC

200 enrolled

Nasopharyngeal Carcinoma

NCT04387266 2020-10-09

To Evaluate the Efficacy and Feasibility of Modified Reduce-volume Target IMRT in the Treatment of Patients With Non-metastatic NPC

Completed

471 enrolled

Nasopharyngeal Carcinoma

NCT03648697 2020-08-11

EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC

20 enrolled

Nasopharyngeal Carcinoma

NCT04421469 2020-06-09

Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC

39 enrolled

Nasopharyngeal Carcinoma

NCT04319471 2020-03-24

Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

70 enrolled

Nasopharyngeal Carcinoma

NCT04220528 2020-01-07

Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC

129 enrolled

Nasopharyngeal Carcinoma

NCT03666221 2018-09-11

Nimotuzumab for Recurrent Nasopharyngeal Carcinoma

67 enrolled

Nasopharyngeal Carcinoma, Recurrence

NCT00697905 2014-11-21

Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma

Phase 2 Completed

18 enrolled

Nasopharyngeal Carcinoma

NCT00577057 2013-08-22

Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer

Phase NA Unknown

798 enrolled

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT01086488 2011-07-08

FOSCAN

66 enrolled

Nasopharyngeal Carcinoma, Recurrence

NCT00563862 2011-06-16

Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)

Phase NA Terminated

465 enrolled

Nasopharyngeal Carcinoma, Carcinoma, Squamous Cell, Nasopharyngeal Neoplasms

NCT00563927 2010-07-07

Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)

Phase NA Unknown

340 enrolled